MARLBOROUGH, Mass., Oct. 11, 2023 Boston Scientific Corporation today announced that the U.S. Food and Drug Administration has approved an expanded indication of the WaveWriter Alpha™.
MARLBOROUGH, Mass. , Jan. 7, 2022 / / Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25 th North American Neuromodulation Society (NANS) annual meeting, in Orlando, Florida , on Jan.13-15, 2022. More than 20 abstracts have been accepted, including three late-breaking presentations.
/PRNewswire/ Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25th North American Neuromodulation Society.